Related Experiment Video
Updated: Aug 12, 2026

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Apoptosis in multiple myeloma: therapeutic implications
1Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
Apoptosis is the primary means by which most radio- and chemotherapy modalities kill cancer cells, and abnormalities in the apoptotic pathways may contribute to disease pathogenesis of cancer. Multiple Myeloma (MM) is a hematological malignancy which will affect 14,000 new individuals in the United States in 2001 and remains irreversibly fatal despite all available therapies. The current review focuses on the studies of apoptotic and survival signaling pathways in MM cells, which have both identified novel apoptotic and anti-apoptotic proteins and provided targets for novel therapeutics.
Insights
This review explores apoptosis and survival pathways in Multiple Myeloma (MM), a fatal blood cancer. Understanding these pathways reveals new therapeutic targets for MM treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Cell Biology
Background:
- Apoptosis is crucial for cancer therapy effectiveness.
- Multiple Myeloma (MM) is a fatal hematological malignancy with limited treatment options.
- Dysregulation of apoptotic pathways is implicated in cancer development and progression.
Purpose of the Study:
- To review the current understanding of apoptotic and survival signaling pathways in Multiple Myeloma cells.
- To identify novel apoptotic and anti-apoptotic proteins involved in MM pathogenesis.
- To highlight potential therapeutic targets for novel MM treatments.
Main Methods:
- Literature review of studies on apoptosis and survival signaling in MM.
- Analysis of identified apoptotic and anti-apoptotic proteins in MM.
- Evaluation of therapeutic strategies targeting these pathways.
Main Results:
- Abnormalities in apoptotic pathways are linked to MM pathogenesis.
- Novel apoptotic and anti-apoptotic proteins have been identified in MM cells.
- These proteins represent potential targets for new MM therapies.
Conclusions:
- Targeting apoptotic and survival pathways offers a promising strategy for MM treatment.
- Further research into these pathways could lead to more effective therapies for Multiple Myeloma.
- Understanding MM cell signaling is key to overcoming treatment resistance.
More Related Videos
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy